These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 26114378)

  • 1. Topical Bevacizumab for the Treatment of Ocular Surface Squamous Neoplasia.
    Asena L; Dursun Altınörs D
    J Ocul Pharmacol Ther; 2015 Oct; 31(8):487-90. PubMed ID: 26114378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subconjunctival bevacizumab injection for ocular surface squamous neoplasia.
    Faramarzi A; Feizi S
    Cornea; 2013 Jul; 32(7):998-1001. PubMed ID: 23538634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of topical bevacizumab for conjunctival intraepithelial neoplasia.
    Özcan AA; Çiloğlu E; Esen E; Şimdivar GH
    Cornea; 2014 Nov; 33(11):1205-9. PubMed ID: 25014150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term outcomes after adjunctive topical 5-flurouracil or mitomycin C for the treatment of surgically excised, localized ocular surface squamous neoplasia.
    Bahrami B; Greenwell T; Muecke JS
    Clin Exp Ophthalmol; 2014; 42(4):317-22. PubMed ID: 23927413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of 9 squamous epithelial carcinoma in situ lesions of the conjunctiva (CIN) with mitomycin C eyedrops in cytological and DNA image cytometric control].
    Cartsburg O; Kersten A; Sundmacher R; Nadjari B; Pomjanski N; Böcking A
    Klin Monbl Augenheilkd; 2001 Jun; 218(6):429-34. PubMed ID: 11488009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitomycin C or interferon as adjuvant therapy to surgery for ocular surface squamous neoplasia: comparative study.
    Blasi MA; Maceroni M; Sammarco MG; Pagliara MM
    Eur J Ophthalmol; 2018 Mar; 28(2):204-209. PubMed ID: 28967069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of diffuse ocular surface squamous neoplasia: efficacy and complications of topical chemotherapy.
    Rudkin AK; Dempster L; Muecke JS
    Clin Exp Ophthalmol; 2015; 43(1):20-5. PubMed ID: 24995542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for ocular surface squamous neoplasia recurrence after treatment with topical mitomycin C and interferon alpha-2b.
    Besley J; Pappalardo J; Lee GA; Hirst LW; Vincent SJ
    Am J Ophthalmol; 2014 Feb; 157(2):287-293.e2. PubMed ID: 24184223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical interferon alfa-2b for management of ocular surface squamous neoplasia in 23 cases: outcomes based on American Joint Committee on Cancer classification.
    Shah SU; Kaliki S; Kim HJ; Lally SE; Shields JA; Shields CL
    Arch Ophthalmol; 2012 Feb; 130(2):159-64. PubMed ID: 22332208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of recurrent corneal and conjunctival intraepithelial neoplasia with topical interferon alfa 2b.
    Boehm MD; Huang AJ
    Ophthalmology; 2004 Sep; 111(9):1755-61. PubMed ID: 15350333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferon for ocular surface squamous neoplasia in 81 cases: outcomes based on the American Joint Committee on Cancer classification.
    Shields CL; Kaliki S; Kim HJ; Al-Dahmash S; Shah SU; Lally SE; Shields JA
    Cornea; 2013 Mar; 32(3):248-56. PubMed ID: 22580436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of intraepithelial and invasive neoplasia of the cornea and conjunctiva: a long-term follow up.
    Zaki AA; Farid SF
    Cornea; 2009 Oct; 28(9):986-8. PubMed ID: 19724215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical 5-fluorouracil 1% for moderate to extensive ocular surface squamous neoplasia in 73 consecutive patients: Primary versus secondary treatment.
    Leventer I; Singh H; Pashaee B; Raimondo CD; Khakh CK; Martin JL; Acharya B; Zhang Q; Lally SE; Shields CL
    Asia Pac J Ophthalmol (Phila); 2024; 13(2):100052. PubMed ID: 38521390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical chemotherapy for giant ocular surface squamous neoplasia of the conjunctiva and cornea: Is surgery necessary?
    Chaugule SS; Park J; Finger PT
    Indian J Ophthalmol; 2018 Jan; 66(1):55-60. PubMed ID: 29283124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Giant ocular surface squamous neoplasia managed with interferon alpha-2b as immunotherapy or immunoreduction.
    Kim HJ; Shields CL; Shah SU; Kaliki S; Lally SE
    Ophthalmology; 2012 May; 119(5):938-44. PubMed ID: 22361315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing Profile and Treatment Outcome in Patients of Ocular Surface Squamous Neoplasia (OSSN).
    Shrestha E; Banstola L; Man I; Gurung B; Gurung H; Adhikari HB
    Nepal J Ophthalmol; 2019 Jul; 11(22):181-188. PubMed ID: 32792695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of conjunctival and corneal epithelial neoplasia with retinoic acid and topical interferon alfa-2b: long-term follow-up.
    Krilis M; Tsang H; Coroneo M
    Ophthalmology; 2012 Oct; 119(10):1969-73. PubMed ID: 22704834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of ocular surface squamous neoplasia with topical Aloe vera drops.
    Damani MR; Shah AR; Karp CL; Orlin SE
    Cornea; 2015 Jan; 34(1):87-9. PubMed ID: 25393094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relapsed ocular squamous surface neoplasia treated with topical interferon alfa-2b.
    Rocha-de-Lossada C; Alba-Linero C; Borroni D; Rachwani-Anil R; Zamorano-Martín F; Rodríguez-Calvo-de-Mora M
    Rom J Ophthalmol; 2020; 64(1):62-65. PubMed ID: 32292860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical interferon or surgical excision for the management of primary ocular surface squamous neoplasia.
    Sturges A; Butt AL; Lai JE; Chodosh J
    Ophthalmology; 2008 Aug; 115(8):1297-302, 1302.e1. PubMed ID: 18294690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.